Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Why is this new/important: Jardiance is currently approved in the US for type 2 diabetes, but not type 1
More importantly, its cardiovascular benefits provide excellent clinical compliance for long-term GLP-1 treatment
Reach out now to discuss your aesthetic goals with one of our professionals by calling : Testing & Screening Accurate and personalized data helps us tailor treatments specifically for you and your current situation
Existing Licensed Alternatives Available on the NHS Licensed weight management medicines currently available in the UK include semaglutide (Wegovy), tirzepatide (Mounjaro), orlistat, liraglutide (Saxenda), and naltrexone/bupropion (Mysimba), subject to eligibility criteria
For weight management, eligible Medicare beneficiaries may qualify for the Medicare GLP-1 Bridge program with a prescription and prior authorization submitted by their healthcare provider
US$ 27.68
US$ 28.64
US$ 25.32
US$ 28.55
US$ 20.19
